HomeHome

About UsAbout Us

About Chimigen Bio

Management Team

Advisory Board

Milestone

Our Science & PipelineOur Science & Pipeline

Technology Platform

Pipeline

R&D Centre

PartneringPartnering

Investors & MediaInvestors & Media

Investors

News

CareeersCareeers

Talent Concept

Opportunities

Contact UsContact Us

中文

English

喜讯 | 凯米生物荣登“德勤中国明日之星”榜单

2025-01-17

Chimigen

Return List

Previous:

凯米生物完成超亿元Pre-A轮融资首关,加速肿瘤治疗性疫苗全球布局

Next:

人物专访 | 凯米生物创始人史跃年:虽诞生于寒冬,但在成都高新区的苗圃中,我们稳健成长
Related information
史跃年博士受邀出席澳中健康及医疗技术合作交流午宴

2025-07-22

SN2001(慢性乙肝治疗性疫苗)在澳启动早期临床试验,凯米生物进入临床开发阶段

2025-07-01

凯米生物完成超亿元Pre-A轮融资首关,加速肿瘤治疗性疫苗全球布局

2025-02-19

喜讯 | 凯米生物荣登“德勤中国明日之星”榜单

2025-01-17

陆汉新博士加入凯米生物,担任研发副总裁

2024-03-04

About Us

About Chimigen Bio

Management Team

Advisory Board

Milestone

Our Science & Pipeline

Technology Platform

Pipeline

R&D Centre

Partnering

Investors & Media

Investors

News

Careeers

Talent Concept

Opportunities

Contact Us

Chimigen Biomedical (Chengdu) Co., Ltd.

1601, Tower F2, Chengdu Tianfu International Bio-Town, Chengdu, Sichuan

Tel:028-60610771

E-mail:contact@chimigen.com

Copyright© 2025 Chimigen Biomedical (Chengdu) Co., Ltd.

蜀ICP备2025128781号-1Designed by iShutime

Wechat